This study successfully verified the activation of the JAK1/2-STAT3 signaling pathway within the tumor tissues of ATC patients, which showed a distinct contrast when compared to papillary thyroid cancer (PTC) and normal thyroid (NT) tissues. The gene discussed is JAK1; the disease is neoplasm.